April 23, 2019

Electroconvulsive Therapy for Neuroleptic Malignant Syndrome

Structured PICO

Does bitemporal ECT improve outcomes in patients with NMS refractory to pharmacotherapy?

Population

Patients with Neuroleptic Malignant Syndrome (NMS) refractory to pharmacotherapy

Intervention

Bitemporal Electroconvulsive Therapy (ECT)

Outcome

Treatment efficacy and tolerability

Bitemporal ECT should be considered early for neuroleptic malignant syndrome refractory to pharmacological interventions.

Abstract

Bitemporal ECT was well tolerated and effective in treating NMS refractory to pharmacotherapy. We suggest that ECT be considered early in cases of NMS that are refractory to pharmacological interventions, especially if the underlying condition is also responsive to ECT.

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Discussion

Authors

Nicholas Morcos

Amy Rosinski

Daniel F. Maixner

Journals

Journal of Ect

Actions

Institutions

University of Michigan

Michigan Medicine

References and Citations

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Discussion

Cite this study

Morcos et al. (Tue,) studied this question.

www.synapsesocial.com/papers/69d88abde9c100a435ae2c34 — DOI: https://doi.org/10.1097/yct.0000000000000600

Also consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

Neuroleptic Malignant Syndrome· 1989 · 176 citations
Neuroleptic malignant syndrome· 1981 · 343 citations
Mortality from neuroleptic malignant syndrome.· 1989 · 287 citations
Lethal catatonia· 1986 · 288 citations
Treatment Choice in Neuroleptic Malignant Syndrome.· 1992 · 51 citations

Electroconvulsive Therapy for Neuroleptic Malignant Syndrome

Structured PICO

Abstract

Citation Network

Connected Papers

Discussion

Authors

Journals

Actions

Institutions

References and Citations

Citation Network

Connected Papers

Discussion

Cite this study

Also consider